| Tretinoin | Approved Investigational Nutraceutical | LRRN3 | 54674 |
downregulated | Tretinoin results in decreased expression of LRRN3 mRNA | 7q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LRRN4 | 164312 |
upregulated | Tretinoin results in increased expression of LRRN4 mRNA | 20p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LRRTM1 | 347730 |
downregulated | Tretinoin results in decreased expression of LRRTM1 mRNA | 2p12 | |
| Tretinoin | Approved Investigational Nutraceutical | LRRTM4 | 80059 |
upregulated | Tretinoin results in increased expression of LRRTM4 mRNA | 2p12 | |
| Tretinoin | Approved Investigational Nutraceutical | LSAMP | 4045 |
downregulated | Tretinoin results in decreased expression of LSAMP mRNA | 3q13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | LSAMP | 4045 |
upregulated | Tretinoin results in increased expression of LSAMP mRNA | 3q13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | LSM14A | 26065 |
downregulated | Tretinoin results in decreased expression of LSM14A mRNA | 19q13.11 | |
| Tretinoin | Approved Investigational Nutraceutical | LSM2 | 57819 |
downregulated | Tretinoin results in decreased expression of LSM2 mRNA | 6p21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | LSM5 | 23658 |
downregulated | Tretinoin results in decreased expression of LSM5 mRNA | 7p14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LSM6 | 11157 |
downregulated | Tretinoin results in decreased expression of LSM6 mRNA | 4q31.22 | |
| Tretinoin | Approved Investigational Nutraceutical | LSP1 | 4046 |
upregulated | Tretinoin results in increased expression of LSP1 mRNA | 11p15.5 | |
| Tretinoin | Approved Investigational Nutraceutical | LST1 | 7940 |
upregulated | Tretinoin results in increased expression of LST1 mRNA | 6p21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | LTB4R | 1241 |
upregulated | Tretinoin results in increased expression of LTB4R mRNA | 14q12 | |
| Tretinoin | Approved Investigational Nutraceutical | LTBP3 | 4054 |
upregulated | Tretinoin results in increased expression of LTBP3 mRNA | 11q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LTK | 4058 |
upregulated | Tretinoin results in increased expression of LTK mRNA | 15q15.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LUM | 4060 |
downregulated | Tretinoin results in decreased expression of LUM mRNA | 12q21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | LUM | 4060 |
upregulated | Tretinoin results in increased expression of LUM mRNA | 12q21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | LXN | 56925 |
upregulated | Tretinoin results in increased expression of LXN mRNA | 3q25.32 | |
| Tretinoin | Approved Investigational Nutraceutical | LY6D | 8581 |
downregulated | Tretinoin results in decreased expression of LY6D mRNA | 8q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LY6E | 4061 |
upregulated | Tretinoin results in increased expression of LY6E mRNA | 8q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LY6K | 54742 |
downregulated | Tretinoin results in decreased expression of LY6K mRNA | 8q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LYAR | 55646 |
downregulated | Tretinoin results in decreased expression of LYAR mRNA | 4p16.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LYL1 | 4066 |
downregulated | Tretinoin results in decreased expression of LYL1 mRNA | 19p13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | LYN | 4067 |
downregulated | Tretinoin results in decreased expression of LYN mRNA | 8q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LYN | 4067 |
upregulated | Tretinoin results in increased expression of LYN mRNA | 8q12.1 | |